Glioma

CASE REPORT
Year
: 2022  |  Volume : 5  |  Issue : 3  |  Page : 99--106

Brain metastases treated with CyberKnife and TomoTherapy: A report of three cases


Li Zhu, Ying Li, Xiangyu Kong, Anna Mu, Ye Zhang, Liping Chen, Xia Li 
 Department of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China

Correspondence Address:
Prof. Xia Li
No. 44 Xiaohe Yan Road, Dadong District, Shenyang City, Liaoning Province
China

This study aimed to compare the safety and efficacy of CyberKnife (CK) versus TomoTherapy for the treatment of brain metastases (BMs). Three cases of BM treated at our hospital – two with CK and one with TomoTherapy – were compared and analyzed. Both treatments showed good therapeutic effects, but CK was more effective. No radiation-related adverse reactions were observed in the three patients. It is concluded that both CK and TomoTherapy can effectively control target lesions by allowing a higher dose in a single treatment while minimizing damage to surrounding normal brain tissue. This can reduce the total number of treatments needed, improve the prognosis of patients, and save medical resources.


How to cite this article:
Zhu L, Li Y, Kong X, Mu A, Zhang Y, Chen L, Li X. Brain metastases treated with CyberKnife and TomoTherapy: A report of three cases.Glioma 2022;5:99-106


How to cite this URL:
Zhu L, Li Y, Kong X, Mu A, Zhang Y, Chen L, Li X. Brain metastases treated with CyberKnife and TomoTherapy: A report of three cases. Glioma [serial online] 2022 [cited 2022 Dec 1 ];5:99-106
Available from: http://www.jglioma.com/article.asp?issn=2589-6113;year=2022;volume=5;issue=3;spage=99;epage=106;aulast=Zhu;type=0